{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:06:45Z","timestamp":1779790005501,"version":"3.53.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to evaluate the effectiveness of online adaptive treatment (ADT) planning for stereotactic body radiotherapy (SBRT) boost on a 1.5-T MR-Linac in cervical cancer patients ineligible for brachytherapy, compared with the conventional position-alignment (PA) assumed dose distributions. This retrospective analysis included 15 treatment plans from five patients, each receiving 21.0\u00a0Gy in three fractions. Daily magnetic resonance imaging (MRIs) were used to compare target and organ-at-risk (OAR) doses between ADT and PA dose distributions. The planning target volume (PTV) was defined as the high-risk clinical target volume (HR-CTV) plus a 3\u00a0mm margin. OARs included the bladder, bowel bag, and planning organ-at-risk volume (PRV) for rectum and sigmoid. Reference plans prioritized OAR constraints while maximizing target coverage; the intended PTV D90% range was 18.9\u201321.6\u00a0Gy. PA doses were reconstructed by dose warping based on alignment of the anterior rectal wall between daily and pretreatment MRIs, whereas ADT plans were reoptimized on the daily MRIs. HR-CTV decreased by 1.6%\u201341.5% between the planning MRI and the first treatment fraction. ADT plans improved PTV D90%, achieved better target coverage and met\u00a0all OAR constraints, whereas PA plans showed dose constraint exceedance across the three fractions, with mean excess doses of 6.89\u2009\u00b1\u20094.39\u00a0Gy to PRV-sigmoid and 5.76\u2009\u00b1\u20093.33\u00a0Gy to PRV-rectum. In conclusion, 1.5-T MR-Linac based SBRT boost with daily online adaptation enhanced tumor coverage and reduced OAR doses, supporting MR-guided online adaptive radiotherapy as a promising option for patients ineligible for brachytherapy.<\/jats:p>","DOI":"10.1093\/jrr\/rrag013","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:29:05Z","timestamp":1771331345000},"page":"467-472","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of online adaptive SBRT boost with 1.5-T MR-Linac for cervical cancer patients unsuitable for brachytherapy: a planning study"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-1370","authenticated-orcid":false,"given":"Kota","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine , Chiba University, 1-8-1 Inohana, Chuo-ku 260-8670 ,","place":["Japan"]},{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , 3-18-22 Honkomagome, Bunkyo-ku 113-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-5227","authenticated-orcid":false,"given":"Kei","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , 3-18-22 Honkomagome, Bunkyo-ku 113-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine , Chiba University, 1-8-1 Inohana, Chuo-ku 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tsuneda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine , Chiba University, 1-8-1 Inohana, Chuo-ku 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine , Chiba University, 1-8-1 Inohana, Chuo-ku 260-8670 ,","place":["Japan"]},{"name":"Department of Radiological Sciences, Komazawa University , 1-23-1 Komazawa, Setagaya-ku 154-8525 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4606-5662","authenticated-orcid":false,"given":"Takashi","family":"Uno","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine , Chiba University, 1-8-1 Inohana, Chuo-ku 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026052605522353400_ref1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American brachytherapy society consensus guidelines for locally advanced carcinoma of the cervix","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Part I: general principles Brachytherapy"},{"key":"2026052605522353400_ref2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2023.11.007","article-title":"Updated trends in the utilization of brachytherapy in cervical cancer in the United States: a surveillance, epidemiology, and end-results study","volume":"119","author":"Han","year":"2024","journal-title":"Int J Radiat Oncol Biology Phys"},{"key":"2026052605522353400_ref3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jjco\/hyy187","article-title":"Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy","volume":"49","author":"Ito","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"2026052605522353400_ref4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.rpor.2018.08.005","article-title":"What is the evidence for the clinical value of SBRT in cancer of the cervix?","volume":"23","author":"Yanez","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"key":"2026052605522353400_ref5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13014-020-1469-8","article-title":"Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy","volume":"15","author":"Leung","year":"2020","journal-title":"Radiat Oncol"},{"key":"2026052605522353400_ref6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clon.2017.01.009","article-title":"The role of stereotactic ablative body radiotherapy in gynaecological cancers: a systematic review","volume":"29","author":"Mendez","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2026052605522353400_ref7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/IGC.0000000000001200","article-title":"Stereotactic body radiation therapy, intensity-modulated radiation therapy, and brachytherapy boost modalities in invasive cervical cancer: a study of the National Cancer Data Base","volume":"28","author":"O\u02bcDonnell","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"2026052605522353400_ref8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11604-024-01566-8","article-title":"Phase I\/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy","volume":"42","author":"Ito","year":"2024","journal-title":"Jpn J Radiol"},{"key":"2026052605522353400_ref9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ygyno.2021.04.010","article-title":"Stereotactic body radiotherapy for the treatment of gynecologic malignancies: passing fancy or here to stay?","volume":"161","author":"Hutten","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2026052605522353400_ref10","doi-asserted-by":"publisher","first-page":"e8190","DOI":"10.7759\/cureus.8190","article-title":"Disease site-specific guidelines for curative radiation treatment during 'limited surgery' and 'hospital avoidance': a radiation oncology perspective from the epicenter of COVID-19 pandemic","volume":"12","author":"Parashar","year":"2020","journal-title":"Cureus"},{"key":"2026052605522353400_ref11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-022-01981-z","article-title":"MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience","volume":"17","author":"Hadi","year":"2022","journal-title":"Radiat Oncol"},{"key":"2026052605522353400_ref12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group\u2606(I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"2026052605522353400_ref13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.21037\/tcr-23-1649","article-title":"Beginning of clinical treatment using the 1.5 tesla MR-Linac system in Japan: a narrative review","volume":"13","author":"Takahashi","year":"2024","journal-title":"Transl Cancer Res"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/3\/467\/67715349\/rrag013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/3\/467\/67715349\/rrag013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T09:52:29Z","timestamp":1779789149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/67\/3\/467\/8571401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrag013","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,1]]}}}